Skip to Content
About Us Become an Authorised Buyer Medical Partners Blog Contact Us
🌐Ship toSelect country
  1. All products
  2. Shop by Area
  3. Chin
  4. Teosyal Puresense Ultra Deep - 2 x 1,2ml
  5. Chin
Pricelist: Default Pricelist
Pricelist: Default Pricelist
Teosyal Puresense Ultra Deep - 2 x 1,2ml

Teosyal Puresense Ultra Deep - 2 x 1,2ml

Teosyal PureSense Ultra Deep is a Teoxane cross-linked hyaluronic acid filler with 0.3% lidocaine, designed for facial contour remodelling, volume restoration/augmentation and correction of minor tissue ptosis in areas such as the cheeks or upper cheeks, positioned in the range's 'volume replenishment' category. For use by licensed, trained medical professionals only.

Cross-Linked Hyaluronic Acid Lidocaine
152.00 € 152.00 €
  • Brand
Contact Us
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand Teosyal®
SKU A5511 Share
Treatment Areas CheeksChinJawlineNose
Tags Cross-Linked Hyaluronic AcidLidocaine

Teosyal PureSense Ultra Deep is Teoxane's high-viscosity cross-linked hyaluronic acid filler, formulated for deep injection to restore facial volume and structure. Its PureSense formulation includes lidocaine for a more comfortable injection experience.

CONCENTRATION

  • Cross-linked hyaluronic acid (high viscosity)
  • Lidocaine hydrochloride 0.3%

THE PACK INCLUDES

  • 2 x 1.2ml Syringes

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Protect from direct sunlight

RESULTS & DURATION

Results typically last 12-15 months, depending on individual metabolism.

INDICATIONS

  • Loss of cheek and mid-face volume
  • Deep facial contouring

TREATMENT AREAS

  • Cheeks
  • Chin
  • Face, general

Teosyal PureSense Ultra Deep is injected into the deep dermis or subcutaneous plane using bolus or fanning technique.

Results are visible immediately, with final results assessed after 2-4 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin